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Abstract
Background The most widely used approach to joint modelling of
repeated measurement and time to event data is to combine a linear
Gaussian random effects model for the repeated measurements with a
log-Gaussian frailty model for the time-to-event outcome, linking the two
through some form of correlation structure between the random effects
and the log-frailty. In this approach, covariates are assumed to affect the
mean response profile of the repeated measurement data.
Objectives Some applications raise substantive questions that cannot be
captured by this structure. For example, an important question in cys-
tic fibrosis (CF) research is to understand the impact of a patient’s lung
function trajectory on their risk of acquiring a variety of infections, and
how this varies at different quantiles of the lung function distribution.
Methods Motivated by this question, we develop a joint quantile mod-
elling framework in this paper with an associated Markov Chain Monte
Carlo algorithm for Bayesian inference.
Results The translation from the common joint model towards quantile
regression succeeds and is applied to CF data from the United Kingdom.
The method helps detecting an overall difference in the relation between
lung function decline and onset of infection in the different quantiles.
Conclusions Joint modelling without taking into account the special het-
eroscedastic structure is not sufficient in certain research question and the
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extensions towards models beyond the mean is necessary.
1 Introduction
Amongst the many statistical methods that have been developed for anlysing
data from longitudinal studies, the term joint modelling refers to the statisti-
cal modelling of data in which each subject provides data on two qualitatively
different kinds of outcome variable: a time-sequence of repeated measurements;
and a (possibly right-censored) time-to-event variable. The extensive literature
on this topic is reviewed in Tsiatis and Davidian [2004], and in a recent text by
Rizopoulos [2012] and O¨zgu¨r et al. [2015]. Most of the joint modelling literature
adopts a hierarchical modelling approach in which the repeated measurement
and time-to-event outcomes are modelled as conditionally independent linear
Gaussian and log-linear proportional hazards models given a latent bivariate
stochastic Gaussian process, say {W1(t),W2(t)} whose components affect the
conditional mean of the measurement process and conditional log-hazard of the
time-to-event process, respectively.
In practice, this approach is usually associated with an inferential focus on how
a subject’s repeated measurement process affects their prognosis for survival,
after adjustment for covariate effects. Quantile regression methods [Koenker
and Bassett, 1978], in contrast, are designed to answer questions concerning the
relationship between a subject’s covariates and the corresponding quantile of
their measured outcomes. Papers that describe quantile regression methods for
repeated measurement outcomes include Koenker [2004] and Geraci [2014] in a
likelihood based scenario, Fenske et al. [2011] in the boosting context, and Yue
and Rue [2011] using a Bayesian approach. To our knowledge, the one paper
that extends this to joint modelling as defined above is Farcomeni and Viviani
[2015].
In this paper, we develop a novel approach to quantile-based joint modelling,
motivated by a question in the epidemiology of cystic fibrosis, a genetic condition
that leads to a progressive deterioration of a patient’s lung function throughout
their life.
In Section 2 of the paper we give a description of cystic fibrosis, the specific re-
search question that motivated this work and the data that we will use to answer
the question. In Section 3 we set out our proposed methodology. We formulate
a location scale mixture representation of the asymmetric Laplace distribution
whose likelihood can be treated like that of a latent Gaussian distribution, thus
allowing the use of tools previously developed for joint modelling based on mean
regression. We also develop an MCMC algorithm for Bayesian inference. In Sec-
tion 4 we describe our analysis of the cystic fibrosis data. Section 5 discusses
some limitations of the current methodology and outlines further work to extend
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its scope. Code is available from the first author.
2 Outline of the problem
Cystic fibrosis (CF) is one of the most common serious genetic diseases in the
Western world. It has an impact on a number of organs, primarily the lung,
pancreas and liver. The disease is characterized by recurrent lung infection and
inflammation with associated long-term lung function decline. Most people with
cystic fibrosis die prematurely as a result of respiratory failure.
Most epidemiological studies of lung function in CF have concentrated on in-
vestigating how a range of risk factors affect the decline in mean lung function
in children and adult populations [Konstan et al., 2007, Salvatore et al., 2011,
Konstan et al., 2012, Salvatore et al., 2012, Taylor-Robinson et al., 2012, 2013].
A number of studies have found that infection with Pseudomonas aeruginosa
(PA) has an accelerating effect on the decline in mean lung function [Rosen-
feld et al., 2012, Taylor-Robinson et al., 2012]. However, this acceleration is
potentially greater and thus more concerning for patients whose lung function
is already relatively poor, i.e. for individuals whose lung function is at lower
quantiles of the distribution. A first step to further explore the impact of PA
on lung function is to set the problem in a quantile regression context [Koenker
and Bassett, 1978]. Instead of assessing the impact of a set of covariates on the
mean, we analyze their impact on selected quantiles. This provides additional
insights without the need to assume a closed form distribution; we give a more
detailed description in Section 3.
Quantile regression has been used rarely in research on pulmonary diseases. Ex-
amples include van Sickle et al. [2011], who showed differences in lung function
decline for groups with different socioeconomic background, Denaro and Bai-
ley [2012], who modelled lung function decline in CF, and Kulich et al. [2005],
who estimated reference equations to be able to classify the lung function level
of CF patients in comparison to other CF patients, rather than to a healthy
population.
In this paper we use data from the UK CF registry, which collects longitudinal
data on all patients with CF living in the UK. The registry currently collects
data on around 10,000 patients who attend annual examinations examinations
where they are assessed for clinical status, pulmonary function and microbiology
of lower respiratory tract secretions. Lung function is measured using forced
expiratory volume in 1 second as a percentage of predicted (%FEV1) which is
an age-standardised measure of lung function. We analyse an extract from the
registry, containing a total of 16,872 %FEV1 measures from the 3,200 patients
who were seen at least twice between 1995 and 2009. Of the 3,200 patients, 1,237
(39%) were infected with PA at some point during the follow-up period. We
aim to develop a better understanding of the connection between the different
levels of decline in the lung function and the risk of PA acquisition.
A quantile regression analysis of the repeated measurements of lung function
reveals clear differences in the impact of PA at different quantiles of %FEV1.
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We fitted the following model,
yτ = β0 + xageβage + xPAβPA + γ0 + γagexage, (1)
where, for each patient, xage is the vector of the age at which %FEV1 was
measured, xPA contains zeros until the onset of infection and years of infection
thereafter, γ0 and γage are random intercept and slope terms, and yτ is the
τ -quantile of %FEV1. For inference on this model, we used the Bayesian soft-
ware tool BayesX (Belitz et al. [2013]). Figure 1 shows that the impact of PA
on lung function decline, as measured by the parameter βPA, is less pronounced
at central and higher quantiles of the distribution. This suggests that infection
with PA has a bigger impact on lung function for patients with worse preexisting
lung function and constitutes a prima facie case for investigating structural dif-
ferences in the relationship between lung function and PA infection at different
quantiles of %FEV1.
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Figure 1: MCMC samples from the posterior distribution of βPA in quantile
regression at nine different quantiles, τ
Joint modelling of the kind described in Section 1 has previously been used to
investigate cystic fibrosis data for the relationship between lung function decline
and survival of CF patients [Barrett et al., 2015, Schluchter et al., 2002]. To best
of our knowledge, the present paper is the first attempt to use quantile regression
methods to understand the relationship between lung function decline and risk
of PA infection.
3 Quantile-based joint modelling
3.1 Mean Regression Bayesian Joint Modelling
We first set out an example of a mean regression joint model proposed in Faucett
and Thomas [1996], which provides the starting point for our qunatile-based
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methodology and our associated Monte Carlo Markov Chain (MCMC) algo-
rithm. The model specification is
yij = ηij,ls(tij , xij) + ηij,l(tij , xij) + εij : j = 1, ..., ni; i = 1, ..., n
εij
iid∼ N(0, σ2) (2)
λˆi(tij) = λ0(tij) exp(αηij,ls(tij , xij) + ηij,s(tij , xij)),
where yij is the jth repeated measurement on the ith of n individuals, tij is the
corresponding measurement time and the ηij,·(tij , xij) are specified functions of
tij , covariates xij and individual-level random effects that have an impact on
the repeated measurements (subscript l), the hazard function (subscript s) or
both (subscript ls).
ηij,s(tij , xij) = 0
ηij,l(tij , xij) = β0 + β1tij
ηij,ls(tij , xij) = γ0i + γ1itij
To estimate the distribution of the survival times we use the partial likelihood
for the hazard rate. Since the composition of the predictor is rather messy we
present the parts in a structured form.
ηij,ls(tij , xij) =
∑p
k=1 fk,ls(tij , xij ,θls) where the fk,ls(tij , xij ,θ) in the sum can
be different kinds of functions of the covariates xij and the time tij . The
parameter vector θls includes all parameters necessary for the correspond-
ing functions. The index ls indicates that this part of the predictor is
assumed to be influential for both parts of the model, the longitudinal
outcomes and the survival times. In the survival part of the model this
part of the predictor is multiplied by the association parameter α.
ηij,l(tij , xij) =
∑p
k=1 fk,l(tij , xij ,θl). The structure of this function is the same
as above, but it contains the covariates being assumed to only be relevant
for the longitudinal part of the model.
ηij,s(tij , xij) =
∑p
k=1 fk,s(tij , xij ,θs). The structure of this function is the same
as above, but it contains the covariates being assumed to only be relevant
for the survival part of the model.
To achieve better legibility we present the functions without the corresponding
arguments (i.e. ηij,ls instead of ηij,ls(tij , xij)), unless the arguments differ from
the tij and xij . This is the case e.g. in the second line of the following formula,
where the function is evaluated at the survival times or the third line, where
the argument of the formula is the integration variable. The likelihood for the
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model of structure (2) results in:
f(Yij |ηij,ls, ηij,l, σ2) = 1√
2piσ2
Ji
exp
− Ji∑
j=1
(yij − (ηij,ls + ηij,l))2
σ2

f(si, di|ηij,ls, ηij,s, α) = {λ0(si) exp (ηij,ls(si, xij) + ηij,s(si, xij))}di (3)
exp
(∫ si
ei
λ0(u) exp (αηij,ls(u, xij) + ηij,s(u, xij)) du
)
,
where n is the number of individuals, Ji the number of observations of the i-
th individual, ei is the time individual i enters the study and si is either the
time of event or last time observation. The dependent variable yij is the j-th
observation of individual i. To cope with the baseline hazard λ0(t), the time
is split into a grid t0, · · · , tK for which λ0(t) is approximated by a piecewise
constant function with values λk for k = 1, · · · ,K. The integral in equation (3)
can hence be approximated by a sum of K integrals. The association parameter
α links the mixed model to the survival analysis and quantifies the strength
of the influence. In the following we will give a short overview over the full
conditionals and refer to the appendix for more detailed calculation. We present
the full conditionals exemplary for linear effects (e.g. ηij,l =
∑K
k=1Xkβl,k), for
possible extensions see section 5.
Predictor part only concerning longitudinal data: The predictor ηij,l is
independent of the survival part of the model. When choosing a Gaussian prior
for the parameters the resulting full conditional is also of Gaussian type. Just as
in standard Bayesian longitudinal modelling, inference on random effects can be
implemented by inducing the correlation within the individual/group by using
an appropriate prior covariance matrix.
Predictor part only concerning survival data: The approach is reverse
to the above presented. The likelihood for the parameters collected in βs can
be presented independently of the longitudinal process. The full conditional can
hence be constructed as if we were only doing a Cox regression. Unfortunately
there is no closed form distribution for the full conditional and we follow Faucett
and Thomas [1996] doing adaptive rejection sampling (ARS).
Predictor part concerning both longitudinal and survival data: The
full conditional for the predictor part ηij,ls is even more complicated than the
survival specific part, since it appears in both parts of the likelihood. We hence
follow Faucett and Thomas [1996] again and use an ARS step.
Model variance: The model variance σ2 is not linked to the survival part
of the model, the full conditional is hence conform with the result in Bayesian
mixed models.
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Baseline Hazard: The relevant part of the likelihood (3) for the full condi-
tional of the λk is the second part, which reduces to a gamma distribution.
Association Parameter: The full conditional for α consists of the second
term of the likelihood and is also generated by ARS.
3.2 Bayesian Quantile Regression
Our proposed adaptation of the above framework to quantile-based joint mod-
elling is as follows:
yij = ηij,ls,τ (tij , xij) + ηij,l,τ (tij , xij) + εij,τ : j = 1, ..., ni; i = 1, ..., n
Fεij,τ (0) = τ
λˆi,τ (tij) = λ0(tij) exp(ατηij,ls,τ (tij , xij) + ηij,s(tij , xij)),
where everything is just as in model 2, except for the error not being distributed
with a Gaussian distribution and the outcome not being the mean, but a quan-
tile. The function Fij,τ (·) denotes the cumulative distribution function of εij,τ .
We hence have one model for each quantile of interest τ . Before we explain,
how this is included into the joint modelling framework, we sketch out the basic
idea of inference in quantile regression. Quantile regression can be estimated by
minimising the so called check function:
ρτ (yij , ηi,τ (xij , tij)) =
{
τ(yij − ηi,τ (xij , tij)) if yij ≥ ηi,τ (xij , tij)
(1− τ)(yij − ηi,τ (xij , tij)) if yij < ηi,τ (xij , tij).
which puts weights on the distance of the observations to the estimated line with
the value τ . Optimising this criterion however is not straightforward, given the
non differentiability due to the absolute value characteristics. The Bayesian
alternative most commonly used, is to use the asymmetric Laplace distribution
(ALD) as an auxiliary likelihood distribution:
p(yi|ηi,τ (xij , tij), σ2, τ) = τ(1− τ)
σ2
exp
(
−y − ηi,τ (xij , tij)
σ2
)
,
which when maximising leads to the same point estimators as minimising the
checkfunction. This detour obviously inherits the problems from the checkfunc-
tion as it still contains the non differentiable part of the latter. Kozumi and
Kobayashi [2011] suggested to use the location scale mixture presentation of the
ALD to circumvent those problems. To this end define weights that follow a
exponential distribution with rate 1σ2 : ω ∼ Exp
(
1
σ2
)
and Z a standard Gaus-
sian random variable Z ∼ N(0, 1). Define the auxiliary variables ξ = 1−2ττ(1−τ)
and φ = 2τ(1−τ) , then Y constructed in the following way:
yij = ηi,τ (xij , tij) + ξωij + φzi
√
ωijσ2
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follows an ALD(η, σ2, τ). This leads to the possibility to construct a regression
model of the form:
yij |ηij,τ (xij , tij), τ, ωij , σ2 ∼ N
(
ηi,τ (xij , tij) + ξωij , σ
2φωij
)
,
which then renders possible to conduct MCMC in the same way as done for
mean regression with an extra sampling step for the above defined weights.
Here a summary of the standard approach to longitudinal modelling:
Fixed and Random effects The priors for the model parameters are chosen
to be Gaussian with the appropriate covariance matrices. The resulting full
conditional is also Gaussian, with slight changes in the parameters compared to
mean regression. Hyperpriors (e.g. to perform selection algorithm) do usually
not have a different impact than in mean regression.
Model Variance If choosing an inverse gamma distribution as a prior for
the model variance, the full conditional is an inverse gamma distribution, too,
again, with slight parameter changes, caused by offset and weights.
Weights The key difference to the mean regression MCMC approach is the
extra sampling step, necessary for the weights. Resulting from the location
scale mixture representation of the ALD, the weights are a priori exponentially
distributed with rate 1/σ2. The full conditional is an inverse Gaussian distri-
bution.
For a more detailed outline see e.g.Waldmann et al. [2013] or Rue et al. [2009].
Given the limited number of changes, having to consider in the transition from
mean to quantile regression, we considered the transition from Gaussian joint
modelling to Quantile regression joint modelling.
3.3 Bayesian Quantile Regression in Joint Modelling
The above described data set shows strong differences in the covariates when
measuring the impact on different quantiles. The structure of the presented
model will hence be extended to a model describing the association between a
mixed model quantile regression and the survival model. The ultimate goal of
this experiment is to model the survival function based on a set of quantiles
mimicking the whole distribution and thus obtaining a more complete informa-
tion on the relation between conditional distribution and survival time.
To achieve this goal we use the above described location scale mixture construc-
tion of the ALD. This makes the necessary adjustments in the likelihood (3)
where the first line has to be replaced by
1√
2piσ2ωijφ
Ji
exp
− Ji∑
j=1
(yij − (ηij + ξωij))2
2σ2ωijφ
 .
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The MCMC algorithm for our quantile regression joint modelling approach is
hence a combination of the results from section 3.1 and section 3.2. The full
conditionals only change slightly in parameters. For detailed information see
the appendix.
4 Analysing the cystic fibrosis registry data
4.1 Model formulation
As described in Section 2, our repeated measurement outcome is %FEV1 and our
time-to-event-outcome is the time of first infection with PA. The longitudinal
predictor ηl,ij(tij) was chosen to contain an intercept and a linear time effect as
well as random intercept and time slope. The shared predictor ηls,ij was chosen
to include the random effects. The list of predictors is:
ηij,s(tij , xij) = 0
ηij,l,τ (tij , xij) = β0 + β1tij
ηij,ls,τ (tij , xij) = γ0i + γ1itij
This is a simple model formulation and by adding the linear fixed time effect
to the longitudinal sub-model, but not to the survival part, we make sure that
the differences in the temporal progression captured but the magnitude of the
quantiles do not interfere with α.
The model was implemented in R Development Core Team [2011], MCMC
chains consisted of a sample of 10.000 with a burn-in period of 1000 and a
thining of nine. The sampling paths showed no inconsistencies.
4.2 Results
We ran the joint Bayesian quantile model for the nine percentiles τ = (0.1, 0.2, . . . , 0.9).
Figure 2 displays the different in the association parameter for the nine different
quantiles. The association parameter was considered significant, if 95% of the
values in the sample are on one side of 0 and the corresponding boxes colored
grey in the figure.
To aid interpretation of these values Figure 3 shows a selection of the longitu-
dinal sub-model for four different quantiles. The black lines display the overall
quantile specific regression estimation, while the grey lines show the deviation
from this overall estimation for individual patients. We can see that the in-
dividual lines scatter rather differently below and above the black lines. The
impact of this deviation on the hazard rate is quantified by α. Negative α val-
ues indicate that the patients which deviate negatively from the overall trend
result in having a multiplicative constant bigger than one and hence have and
increased risk of infection. If we look at the example of τ = 0.10 the negative
9
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Figure 2: MCMC samples of the association parameter α for different quantiles
α (see Figure 2) implies that risk of infection is higher for patients, whose lines
lie in the group below the dark line in the upper left figure in 3. Positive α
have the opposite effect: for the more central quantiles, we can see that the α
values indicate that the individuals above the line have a higher risk of infection
whereas the risk is lower for individuals below the line. Please note for the direct
interpretation that the individuals are denser around the mean trajectory for
the central quantiles and the fact that the α values are higher does not mean
that the influence is higher. Note that the individuals are not necessarily in the
same group for the different quantiles. The overall conclusion is that there are
differences in the relation between lung function decline and onset of infection
in the different quantiles. Note that the purpose of this paper is to outline the
utility of our statistical approach. Future analyses of CF data using the full
dataset and taking into account a complete range of covariates will clarify the
relationship between lung function and onset of infection with PA.
5 Summary and Outlook
We have shown how joint models for repeated measurement and time-to-event
outcomes can be adapted to include ideas from quantile regression. The pro-
posed model could be extended in various ways. One such extension would be to
use to use lagged effects between the repeated measurement and time-to-event
components of the model. A second extension would be a model in which the
hazard for the time-to-event outcome depends on the rate of change in the re-
peated measurement process. For a random intercept and slope model, this is
straightforward, we simply include the random slope as shared random effect.
More generally, the model would need to include a differentiable stochastic pro-
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Figure 3: Linear effect of age on lung function with: overall effect in black,
individual effects grey
cess, W (t) say, amongst the random effects in the repeated measurement com-
ponent, with the derivative of W (t) included in the time-to-event component.
Estimation of effects of this kind is difficult without relatively long, frequently
observed series of repeated measurements on individual patients. A third exten-
sion, also straightforward in principle but difficult in practice without extensive
follow-up data, would be to allow non-linear time-varying effects.
Including more elaborate effects should be straight forward, since the location
scale mixture allows for extending the predictor by numerous effects [Waldmann
et al., 2013]. Besides nonlinear effect also spatial information could be included.
Modelling the random effects with a Dirichlet process mixture and then includ-
ing the resulting cluster information into the survival model could also lead to
interesting insights into the structure of infection.
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A further interesting extension would be to replace the quantile model by a
Bayesian distributional regression as done by Klein et al. [2015] or with any
other kind of non mean regression in order to get a deeper understanding of the
connection between a longitudinal process and time to event observations.
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A Full Conditionals
A.1 Bayesian Quantile Regression
This is the likelihood setup resulting from location scale mixture explained in
section 3.2:
y|η,w, τ, σ2 ∼ N(η + ξw, σ2φW )
wi ∼ Exp
(
1
σ2
)
, i = 1, . . . , n
W = diag(wi)
ξ =
1− 2τ
τ(1− τ)
φ =
2
τ(1− τ)
We demonstrate the calculation for the example of a linear effect ηj = Xβ,
which forms part of the assumed additive predictor η =
∑p
j=1 ηj . We assign β
a Gaussian prior N(µβ,Σβ) define the sub predictor η−j = η − ηj . Then we
get a Gaussian full conditional for parameter vector β. This result is generasible
towards all kinds of effects with Gaussian prior (e.g. P-Splines, Gaussian Markov
random fields or random effects).
p(β|·) ∝ exp
(
1
2
(β − µβ)>Σ−1β (β − µβ)
)
exp
(
1
2σ2φ
(
Xβ − (y − η−j)
)>
W−1
(
Xβ − (y − η−j)
))
β|· ∼ N(µ∗β ,Σ∗β)
µ∗β = Σ
∗
β
(
1
σ2φ
W−1X>(y − η−j) + Σβ−1µβ
)
Σ∗β =
(
1
σ2φ
X>W−1X + Σ−1β
)−1
.
We assign an inverse gamma distribution as prior to the variance parameter σ2:
σ2 ∼ IG(a0, b0).
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f(σ2|·) ∝ f(y|η, τ,W )f(W |σ2)f(σ2)
∝
(
1
σ2φ
)n
2
|W |n2 exp
−
1
σ2
(η + ξW − y)> 1
2φ
W−1(η + ξW − y)︸ ︷︷ ︸
(?)
(
1
σ2
)n
exp
(
1
σ2
n∑
i=1
wi
)
σ2
−a0−1
exp
(
− b0
σ2
)
∝ σ2−(n+
n
2+α0)−1 exp
(
−b0 + (?) +
∑n
i=1 wi
σ2
)
σ2|· ∼ IG
(
a0 +
3n
2
, b0 +
1
2φ
n∑
i=1
w−1i (yi − ηi − ξwi)2 +
n∑
i=1
wi
)
.
The full conditionals for the weights are calculated separately for each wi, i =
1, . . . , n:
f(wi|·) ∝ f(yi|ηi, σ2, wi, τ)f(wi|σ2)
∝ 1√
wi
exp
{
−1
2
(yi − ηi − ξwi)2
φwiσ2
}
(
1
σ2
)
exp
(
1
σ2
wi
)
=
1√
wi
exp
{
1
2
(yi − ηi)2 − 2(yi − ηi)ξwi + w2i (ξ2 + 2φ)
φwiσ2
}
=
1√
wi
exp
−
(yi − ηi)2
2σ2φ︸ ︷︷ ︸
(?)
·
1− 2ξwiyi−ηi + w2i
ξ2+2φ
(yi−ηi)2
wi

=
1√
wi
exp
−(?) · (w
−1
i )
2 − 2ξ(yi−ηi)w
−1
i +
ξ2+2φ
(yi−ηi)2
w−1i

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With the density transformation theorem follows:
p(w−1i |·) ∝ (w−1i )
2
3 exp
−(?) ·
1
w−1i
·
w−1i −
√
ξ2 + 2φ
(yi − ηi)2︸ ︷︷ ︸
µwi

2
= (w−1i )
2
3 exp
−
1
2(µwi)2
· (ξ
2 + 2φ)
σ2φ︸ ︷︷ ︸
λw
(w−1i − µwi)
2
w−1i

⇒ w−1i ∼ InvGauss(µwi, λw).
A.2 Bayesian Joint Mean Regression
This is the likelihoodsetup from section 3.1:
f(Yij |ηij,ls, ηij,l, σ2) = 1√
2piσ2
Ji
exp
− Ji∑
j=1
(yij − (ηij,ls + ηij,l))2
σ2

f(si, di|ηij,ls, ηij,s, α) = {λ0(si) exp (ηij,ls(si, xij) + ηij,s(si, xij))}di
exp
(∫ si
ei
λ0(u) exp (αηij,ls(u, xij) + ηij,s(u, xij)) du
)
,
To show the full conditional for effects on the longitudinal sub predictor we
again demonstrate the calculation for the example of a linear effect ηl,j = Xβ,
which forms part of the assumed additive predictor ηl =
∑p
j=1 ηl,j . We assign β
a Gaussian prior N(µβ,Σβ) define the sub predictor ηl,−j = ηl−ηl,j . Then we
get a Gaussian full conditional for parameter vector β. This result is generasible
towards all kinds of effects with Gaussian prior (e.g. P-Splines, Gaussian Markov
random fields or random effects). Please note that β is merely an example and
indices are thus suppressed.
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p(β|·) ∝ exp
(
1
2
(β − µβ)>Σ−1β (β − µβ)
)
exp
(
1
2σ2
(
Xβ − (y − ηl,−j − ηls)
)> (
Xβ − (y − ηl,−j − ηls)
))
β|· ∼ N(µ∗β ,Σ∗β)
µ∗β = Σ
∗
β
(
1
σ2
X>(y − ηl,−j − ηls) + Σβ−1µβ
)
Σ∗β =
(
1
σ2
X>X + Σ−1β
)−1
.
We assign a gamma distribution as prior to the pieces of the piecewise constant
baseline hazard λk: σ
2 ∼ G(a0, b0).
p(λk|·) ∝ f(y|η, τ)f(λk)
λa0+1k exp(−b0λk)
λ
∑n
i=1 dik
k exp
(
−λk
n∑
i=1
∫ min(tk+1,si)
max(tk,ei)
exp (αηij,ls(u, xij) + ηij,s(u, xij)) du
)
λ
∑n
i=1 dik+a0+1
k exp
−λk
(
b0 +
n∑
i=1
∫ min(tk+1,si)
max(tk,ei)
exp (αηij,ls(u, xij) + ηij,s(u, xij)) du
)
︸ ︷︷ ︸
bλk

λk|· ∼ Gamma
(
n∑
i=1
dik + a0, bλk
)
We assign an inverse gamma distribution as prior to the variance parameter σ2:
σ2 ∼ IG(a0, b0).
f(σ2|·) ∝ f(y|ηl,ηls, σ2)f(σ2)
∝
(
1
σ2
)n
2
exp
− 1σ2 (ηl + ηls − y)>(η + ηls − y)︸ ︷︷ ︸
(?)

σ2
−a0−1
exp
(
− b0
σ2
)
∝ σ2−(
n
2+α0)−1 exp
(
−b0 + (?)
σ2
)
16
δ2|· ∼ IG
(
a0 +
n
2
, b0 +
1
2
n∑
i=1
(yi − ηli − ηlsi)2
)
.
A.3 Bayesian Joint Quantile Regression
Everything is analogous to the above. The results gets either obvious, when
extending what is described in A.1 by the extra sub-predictor ηls or when
replacing the Gaussian distribution in A.2 by the location scale mixture.
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